Table 1.
Scenarios for the infant vaccine |
Scenarios for the adolescent and adult vaccine |
||||
---|---|---|---|---|---|
Base-case | Accelerated scale-up | Base-case | Accelerated scale-up | Routine-only | |
Ages targeted | Routine for infants | Routine for infants | Routine for those aged 9 years and a one-time vaccination campaign scaled up across 5 years for those aged 10 years or older | Routine for those aged 9 years and a one-time vaccination campaign in 2025 for those aged 10 years or older | Routine for those aged 9 years |
Introduction year | Country-specific | 2025 | Country-specific | 2025 | Country-specific |
Vaccine roll-out trend | 5-year linear scale-up to coverage | Instant scale-up to coverage | 5-year linear scale-up to coverage | Instant scale-up to coverage | 5-year linear scale-up to coverage |
Coverage target (low, medium, and high) | 75%, 85%, and 95% | 75%, 85%, and 95% | 70%, 80%, and 90% for those aged 9 years; 50%, 70%, and 90% for those aged 10 years and older | 70%, 80%, and 90% for those aged 9 years; 50%, 70%, and 90% for those aged 10 years and older | 70%, 80%, and 90% for those aged 9 years; 50%, 70%, and 90% for those aged 10 years and older |